159 related articles for article (PubMed ID: 35036444)
1. DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis.
Luo F; Wang Z; Chen S; Luo Z; Wang G; Yang H; Tang L
Biomed Res Int; 2022; 2022():9914778. PubMed ID: 35036444
[TBL] [Abstract][Full Text] [Related]
2. Systematic Characterization of the Expression and Prognostic Values of Formin-Like Gene Family in Gastric Cancer.
Nie H; Mei J; Zhang Q; An F; Zhan Q
DNA Cell Biol; 2020 Sep; 39(9):1664-1677. PubMed ID: 32551946
[TBL] [Abstract][Full Text] [Related]
3. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
4. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
5. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
6. PDGFRB is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Liu B; Xiao X; Lin Z; Lou Y; Zhao L
Cancer Biomark; 2022; 34(2):251-264. PubMed ID: 34958001
[TBL] [Abstract][Full Text] [Related]
7. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Hou W; Kong L; Hou Z; Ji H
BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
[TBL] [Abstract][Full Text] [Related]
8. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
Zhao X; Zou J; Wang Z; Li G; Lei Y
Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
11. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
Wang M; Li C; Liu Y; Wang Z
Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
[TBL] [Abstract][Full Text] [Related]
12.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer.
Tong M; Lu W; Liu H; Wu J; Jiang M; Wang X; Hao J; Fan D
Biomed Res Int; 2019; 2019():2957821. PubMed ID: 31380415
[TBL] [Abstract][Full Text] [Related]
14. The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
Kanda M; Nomoto S; Oya H; Takami H; Shimizu D; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S214-21. PubMed ID: 25743330
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.
Li L; Huang S; Yao Y; Chen J; Li J; Xiang X; Deng J; Xiong J
World J Surg Oncol; 2020 Dec; 18(1):324. PubMed ID: 33292276
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
18. PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer.
Hu L; Zhang P; Sun W; Zhou L; Chu Q; Chen Y
Medicine (Baltimore); 2020 May; 99(19):e19957. PubMed ID: 32384443
[TBL] [Abstract][Full Text] [Related]
19. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
20. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
